PW Medtech Group Ltd. (PWE) Ratios
PW Medtech Group Ltd. Ratios
DE:PWE's free cash flow for Q2 2026 was $79.74M. For the 2026 fiscal year, DE:PWE's free cash flow was decreased by $-24.94M and operating cash flow was $104.68M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.89 | 11.80 | 13.61 | 11.59 | 24.82 |
| Quick Ratio | 10.22 | 11.12 | 12.70 | 10.81 | 24.50 |
| Cash Ratio | 8.32 | 9.48 | 10.65 | 8.23 | 21.87 |
| Solvency Ratio | 0.65 | 0.69 | 0.77 | 0.52 | 6.28 |
| Operating Cash Flow Ratio | 1.11 | 1.79 | 1.41 | 1.60 | 0.36 |
| Short-Term Operating Cash Flow Coverage | 16.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 2.00B | $ 1.74B | $ 1.70B | $ 1.59B | $ 2.47B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.33 | 1.30 | 1.27 | 1.26 | 1.03 |
| Debt Service Coverage Ratio | 15.00 | 624.97 | 1970.38 | 315.97 | 131.62 |
| Interest Coverage Ratio | 169.86 | 479.90 | 1216.86 | 264.75 | 1125.18 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -6.71 | -6.16 | -4.82 | -7.85 | -29.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 49.48% | 54.55% | 56.42% | 55.67% | 61.19% |
| EBIT Margin | 15.27% | 22.63% | 34.25% | 18.29% | 17.34% |
| EBITDA Margin | 32.25% | 35.24% | 48.81% | 32.69% | 28.73% |
| Operating Profit Margin | 14.85% | 23.34% | 27.76% | 22.88% | 250.82% |
| Pretax Profit Margin | 20.04% | 29.88% | 34.23% | 29.39% | 271.73% |
| Net Profit Margin | 11.46% | 19.61% | 22.69% | 19.75% | 272.34% |
| Continuous Operations Profit Margin | 16.42% | 25.04% | 30.37% | 24.01% | 272.34% |
| Net Income Per EBT | 57.20% | 65.63% | 66.29% | 67.22% | 100.22% |
| EBT Per EBIT | 134.91% | 128.01% | 123.30% | 128.41% | 108.33% |
| Return on Assets (ROA) | 1.80% | 2.92% | 2.97% | 2.13% | 18.88% |
| Return on Equity (ROE) | 2.39% | 3.80% | 3.79% | 2.69% | 19.49% |
| Return on Capital Employed (ROCE) | 2.44% | 3.60% | 3.75% | 2.55% | 17.86% |
| Return on Invested Capital (ROIC) | 1.99% | 3.02% | 3.32% | 2.65% | 20.61% |
| Return on Tangible Assets | 2.58% | 4.27% | 3.63% | 2.63% | 19.76% |
| Earnings Yield | 5.39% | 10.40% | 13.00% | 12.17% | 57.83% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.15 | 8.28 | 6.15 | 6.01 | 2.99 |
| Payables Turnover | 7.07 | 8.36 | 7.56 | 8.55 | 9.96 |
| Inventory Turnover | 2.86 | 2.91 | 2.15 | 1.80 | 3.18 |
| Fixed Asset Turnover | 0.88 | 0.83 | 0.72 | 0.56 | 0.43 |
| Asset Turnover | 0.16 | 0.15 | 0.13 | 0.11 | 0.07 |
| Working Capital Turnover Ratio | 0.41 | 0.40 | 0.37 | 0.25 | 0.08 |
| Cash Conversion Cycle | 245.37 | 126.09 | 180.52 | 220.77 | 200.25 |
| Days of Sales Outstanding | 169.53 | 44.10 | 59.32 | 60.68 | 121.94 |
| Days of Inventory Outstanding | 127.44 | 125.63 | 169.49 | 202.79 | 114.95 |
| Days of Payables Outstanding | 51.60 | 43.65 | 48.29 | 42.70 | 36.65 |
| Operating Cycle | 296.97 | 169.73 | 228.81 | 263.47 | 236.90 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.16 | 0.21 | 0.13 | 0.17 | 0.02 |
| Free Cash Flow Per Share | 0.09 | 0.16 | 0.08 | 0.14 | 0.02 |
| Dividend Paid and CapEx Coverage Ratio | 1.02 | 1.54 | 1.37 | 5.13 | 0.02 |
| Capital Expenditure Coverage Ratio | 2.29 | 4.42 | 2.58 | 5.13 | 3.29 |
| Operating Cash Flow Coverage Ratio | 10.94 | 26.37 | 187.08 | 63.48 | 15.25 |
| Operating Cash Flow to Sales Ratio | 0.29 | 0.41 | 0.31 | 0.50 | 0.14 |
| Free Cash Flow Yield | 7.75% | 16.99% | 10.96% | 24.88% | 2.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.54 | 9.61 | 7.69 | 8.22 | 1.73 |
| Price-to-Sales (P/S) Ratio | 2.13 | 1.89 | 1.74 | 1.62 | 4.71 |
| Price-to-Book (P/B) Ratio | 0.44 | 0.37 | 0.29 | 0.22 | 0.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.91 | 5.88 | 9.12 | 4.02 | 49.30 |
| Price-to-Operating Cash Flow Ratio | 7.27 | 4.55 | 5.58 | 3.24 | 34.32 |
| Price-to-Earnings Growth (PEG) Ratio | -0.51 | -94.03 | 0.17 | -0.10 | 0.10 |
| Enterprise Value Multiple | -0.12 | -0.81 | -1.25 | -2.89 | -12.88 |
| Enterprise Value | -30.98M | -220.30M | -410.57M | -506.46M | -1.00B |
| EV to EBITDA | -0.12 | -0.81 | -1.25 | -2.89 | -12.88 |
| EV to Sales | -0.04 | -0.29 | -0.61 | -0.94 | -3.70 |
| EV to Free Cash Flow | -0.23 | -0.89 | -3.18 | -2.34 | -38.74 |
| EV to Operating Cash Flow | -0.13 | -0.69 | -1.95 | -1.88 | -26.97 |
| Tangible Book Value Per Share | 2.18 | 2.05 | 2.49 | 2.35 | 2.31 |
| Shareholders’ Equity Per Share | 2.62 | 2.57 | 2.58 | 2.52 | 2.42 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.16 | 0.11 | 0.18 | -0.00 |
| Revenue Per Share | 0.55 | 0.50 | 0.43 | 0.34 | 0.17 |
| Net Income Per Share | 0.06 | 0.10 | 0.10 | 0.07 | 0.47 |
| Tax Burden | 0.57 | 0.66 | 0.66 | 0.67 | 1.00 |
| Interest Burden | 1.31 | 1.32 | 1.00 | 1.61 | 15.67 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.06 | 0.08 | 0.07 |
| SG&A to Revenue | 0.33 | 0.31 | 0.18 | 0.23 | 0.23 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.62 | 1.39 | 0.91 | 2.54 | 0.05 |
Currency in CNY
